CBU
LXRX icon

CIBC Bancorp USA’s Lexicon Pharmaceuticals LXRX Stock Holding History

CIBC Bancorp USA’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Sell
13,740
-1,786,260
-99% -$3.48M ﹤0.01% 1905
2026
Q1 		$2.81M Buy
+1,800,000
New +$2.62M ﹤0.01% 844

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CIBC Bancorp USA's LXRX Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Lexicon Pharmaceuticals (LXRX) stake by 99% in Q2 2026, selling an estimated $3.48M and leaving 13,740 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

CIBC Bancorp USA first reported a position in LXRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.81M in Q1 2026. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • CIBC Bancorp USA held 13,740 shares of Lexicon Pharmaceuticals worth $33K as of Q2 2026.
  • CIBC Bancorp USA sold 1,786,260 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $3.48M.
  • Lexicon Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1905 holding.
  • CIBC Bancorp USA first reported a position in Lexicon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Lexicon Pharmaceuticals position peaked at $2.81M in Q1 2026.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.